Please login to the form below

Not currently logged in
Email:
Password:

Deloitte

This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.

Health insurers will test blockchain for data handling

Health insurers will test blockchain for data handling

A Deloitte report on the application of blockchain to healthcare published in 2016 predicted that the technology could “provide a new model for health information exchanges (HIE) by making electronic medical

Latest news

  • Pharma is ‘getting lower returns on R&D’ Pharma is ‘getting lower returns on R&D’

    Pharma is ‘ getting lower returns on R&D’. And Deloitte says the number of drugs in late-stage trials tumbled by 16%. ... almost $2bn compared to $1.2bn in 2010 when the annual survey - by Deloitte’s Centre for Health Solutions - was first conducted

  • Real-world evidence Real-world evidence

    life science partner and RWE specialist at analysts Deloitte. “

  • Brexit: Medical research and the EU referendum Brexit: Medical research and the EU referendum

    In the interests of balance. In February, Karen Taylor, research director for Deloitte's UK Centre for Health Solutions, authored a corporate blog on the potential impact of Brexit for the

  • Study shows R&D returns too low in pharma to be sustainable Study shows R&D returns too low in pharma to be sustainable

    The numbers simply do not add up for life sciences R&D to generate an appropriate return," notes Deloitte. ... While the outlook shows uncertain times for the industry, the solutions appear to be relatively straightforward," commented Neil Lesser, life

  • For richer or poorer For richer or poorer

    Deloitte's Global Human Capital Trends 2015 says that the balance of power in the employer/employee relationship has shifted 'making today's employees more like customers or partners than subordinates.' ... As such, Deloitte's report urges business

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • The rise of real-world evidence The rise of real-world evidence

    More than half the leading life science companies polled by Deloitte in 2017 were developing or significantly improving their real-world data (RWD) capabilities.

  • A quest for innovative solutions A quest for innovative solutions

    The report from analysts Deloitte in December last year, A New Future for R&D?, highlighted diminishing revenue returns from traditional drug development models but stated: ‘We see opportunities for biopharma

  • Digitally yours: How to build effective relationships in virtual space Digitally yours: How to build effective relationships in virtual space

    It is not all about saving though. A 2015 Deloitte forecast estimates considerable growth opportunities in the global mobile and digital health market, with a forecasted rise from $2.4 billion

  • Deal Watch December 2015 Deal Watch December 2015

    December saw the release of reports by two of the top accountancy and consulting groups, PWC and Deloitte. ... Deloitte and GlobalData's report Measuring the return from pharmaceutical innovation 2015 - transforming R&D returns in uncertain times

  • The Chinese diabetes challenge The Chinese diabetes challenge

    However, according to a report published by audit and consulting firm Deloitte, China's Ministry of Civil Affairs has set an ambitious target to train six million caregivers by the end

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics